1. Pink Sheet

EU Pharma Reform: Industry Pushes For Early Roll-Out Of Electronic Product Information

 
• By Vibha Sharma

Pharmaceutical industry says the transition from paper to electronic product information, as part of EU pharmaceutical reforms, should not be held back by member states' readiness.

Woman typing on laptop at office workplace in background. Concept of working process, internet surfing, online business education. Student send e-mail. Close up view. Medical healthcare icons
Electronic Product Information allows access to the most up-to-date information (Shutterstock)

A pan-EU task force of drug companies, representing the research-based, generics and self-care pharmaceutical industries, has devised strategies to facilitate the earlier implementation of electronic product information (ePI) and improve the content of patient leaflets, in line with ongoing reforms to the EU pharmaceutical legislation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from EU Pharma Legislation Reform

More from Pink Sheet

Pink Sheet Podcast: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval

 
• By Derrick Gingery, Sarah Karlin-Smith, and Sue Sutter

Pink Sheet reporter and editors discuss the most recent senior staff departures at the FDA and their impact on the agency, as well as Commissioner Martin Makary’s plans for a new approval pathway and a combined adverse event database as outlined in an interview with a podcast host.

Vertex’s Alyftrek For CF Among Six Orphans On Track For Pan-EU Approval

 
• By Eliza Slawther

The European Medicines Agency has recommended 16 drugs for EU-wide approval, including Vertex’s cystic fibrosis drug Alyftrek and five other orphans.

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.